Recent Improvements in Racial Disparity in the Treatment of Hepatocellular Carcinoma: How Times Have Changed

[1]  H. Pitt,et al.  Albumin-Bilirubin Score vs Model for End-Stage Liver Disease in Predicting Post-Hepatectomy Outcomes. , 2020, Journal of the American College of Surgeons.

[2]  Patricia D. Jones,et al.  Socioeconomic And Survival Differences Among Minorities With Hepatocellular Carcinoma In Florida , 2019, Journal of hepatocellular carcinoma.

[3]  Ronald C. Chen,et al.  The Impact of the Affordable Care Act on Disparities in Private and Medicaid Insurance Coverage among Patients Under 65 with Newly Diagnosed Cancer. , 2019, International journal of radiation oncology, biology, physics.

[4]  J. Marrero,et al.  Racial and Ethnic Differences in Presentation and Outcomes of Hepatocellular Carcinoma , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[5]  H. El‐Serag,et al.  Epidemiology and Management of Hepatocellular Carcinoma. , 2019, Gastroenterology.

[6]  Paul L. Martin,et al.  The Impact of Race on Survival After Hepatocellular Carcinoma in a Diverse American Population , 2018, Digestive Diseases and Sciences.

[7]  R. Wong,et al.  Medicaid and Uninsured Hepatocellular Carcinoma Patients Have More Advanced Tumor Stage and Are Less Likely to Receive Treatment , 2017, Journal of clinical gastroenterology.

[8]  D. McCormick,et al.  The Affordable Care Act: implications for health-care equity , 2017, The Lancet.

[9]  elliot k fishman,et al.  Association of socioeconomics, surgical therapy, and survival of early stage hepatocellular carcinoma. , 2017, The Journal of surgical research.

[10]  Elaine Xu,et al.  Hepatocellular Carcinoma and Academic Skills Workshop cosponsored by Hepatobiliary Surgery and Nutrition and AME Publishing Company. , 2016, Hepatobiliary surgery and nutrition.

[11]  S. Stewart,et al.  Racial/ethnic disparities in hepatocellular carcinoma treatment and survival in California, 1988-2012 , 2016, World journal of gastroenterology.

[12]  Timothy M Pawlik,et al.  Racial disparities in treatment and survival of patients with hepatocellular carcinoma in the United States. , 2016, Hepatobiliary surgery and nutrition.

[13]  M. Nguyen,et al.  Treatment Outcomes With First-line Therapies With Entecavir and Tenofovir in Treatment-Naive Chronic Hepatitis B Patients in a Routine Clinical Practice , 2016, Journal of clinical gastroenterology.

[14]  R. Wong,et al.  Race/Ethnicity-specific Disparities in Hepatocellular Carcinoma Stage at Diagnosis and its Impact on Receipt of Curative Therapies , 2015, Journal of clinical gastroenterology.

[15]  D. Abbott,et al.  Does race affect management and survival in hepatocellular carcinoma in the United States? , 2015, Surgery.

[16]  D. Abbott,et al.  Disparities in care for patients with curable hepatocellular carcinoma. , 2015, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[17]  Y. Rotman,et al.  Emerging trends in hepatocellular carcinoma incidence and mortality , 2015, Hepatology.

[18]  L. Nguyen,et al.  Approximately one‐half of patients with early‐stage hepatocellular carcinoma meeting Milan criteria did not receive local tumor destructive or curative surgery in the post‐MELD exception era , 2014, Cancer.

[19]  M. Choti,et al.  Surgical Therapy for Early Hepatocellular Carcinoma in the Modern Era: A 10-Year SEER-Medicare Analysis , 2013, Annals of surgery.

[20]  Chao-Long Chen,et al.  Why does living donor liver transplantation flourish in Asia? , 2013, Nature Reviews Gastroenterology &Hepatology.

[21]  A. Singal,et al.  Meta‐analysis: underutilisation and disparities of treatment among patients with hepatocellular carcinoma in the United States , 2013, Alimentary pharmacology & therapeutics.

[22]  C. Lo.  Deceased donation in Asia: Challenges and opportunities , 2012, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[23]  E. Ward,et al.  Persistent disparities in liver transplantation for patients with hepatocellular carcinoma in the United States, 1998 through 2007 , 2011, Cancer.

[24]  Luigi Mansi,et al.  AJCC Cancer Staging Handbook: from the AJCC Cancer Staging Manual (7th edition) , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[25]  J. Dimick,et al.  Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma. , 2010, Archives of surgery.

[26]  L. Roberts,et al.  Epidemiology and management of hepatocellular carcinoma. , 2010, Infectious disease clinics of North America.

[27]  A. Neugut,et al.  Racial and insurance disparities in the receipt of transplant among patients with hepatocellular carcinoma , 2010, Cancer.

[28]  S. Bhatia,et al.  Race, ethnicity, and socioeconomic status influence the survival of patients with hepatocellular carcinoma in the United States , 2010, Cancer.

[29]  N. Kemmer,et al.  Liver Transplantation Trends and Survival in the Asian Population , 2009, Transplantation.

[30]  D. Corley,et al.  Survival Differences by Race/Ethnicity and Treatment for Localized Hepatocellular Carcinoma Within the United States , 2009, Digestive Diseases and Sciences.

[31]  A. Neugut,et al.  Racial Disparities in Utilization of Liver Transplantation for Hepatocellular Carcinoma in the United States, 1998–2002 , 2008, The American Journal of Gastroenterology.

[32]  M. Choti,et al.  Racial and Geographic Disparities in the Utilization of Surgical Therapy for Hepatocellular Carcinoma , 2007, Journal of Gastrointestinal Surgery.

[33]  S. Asch,et al.  Surgery for Hepatocellular Carcinoma: Does It Improve Survival? , 2004, Annals of Surgical Oncology.

[34]  H. Pitt,et al.  Hepatocellular carcinoma: multimodality management. , 2001, Surgery.

[35]  M. Saadeh,et al.  Liver , 2016, Laboratory Investigation.

[36]  L. Kao,et al.  Race not rural residency is predictive of surgical treatment for hepatocellular carcinoma: Analysis of the Texas Cancer Registry , 2016, Journal of surgical oncology.